Dr reddy's financials
WebView the latest Dr. Reddy's Laboratories Ltd. ADR (RDY) stock price, news, historical charts, analyst ratings and financial information from WSJ. WebJan 29, 2024 · Net Finance income at Rs. 493 million compared to Rs. 419 million in Q3 FY20. Profit before Tax at Rs. 2.8 billion, which is 5.8% of revenues. Profit after Tax at …
Dr reddy's financials
Did you know?
WebFunding. Dr. Reddy’s Laboratories has raised a total of $6M in funding over 2 rounds. Their latest funding was raised on Oct 3, 2024 from a Post-IPO Equity round. Dr. Reddy’s Laboratories is registered under the ticker FRA:RDDA . Dr. Reddy’s Laboratories is funded by 2 investors. LIC and MAPE Advisory Group are the most recent investors. WebApr 12, 2024 · Discover historical prices for RDY stock on Yahoo Finance. View daily, weekly or monthly format back to when Dr. Reddy's Laboratories Limited stock was issued.
WebLatest Financials - Dr. Reddys Laboratories Ltd. Standalone Consolidated; TTM EPS (₹) 141.7: 218.8: ... Dr. Reddy’s Laboratories Limited commenced its generics business in India in 1986 and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative ... WebFiscal year is April-March. All values INR Millions. 2024 2024 2024 2024 2024 5-year trend; Net Income before Extraordinaries-----
WebDr. Reddy's Laboratories Weblast month Morningstar. Analyst Report: Dr. Reddy's Laboratories Limited Headquartered in India, Dr. Reddy’s Laboratories develops and manufactures generic pharmaceutical products sold across ...
WebDr. Reddys Laboratories Ltd. NSE Symbol: DRREDDY BSE Code: 500124 ISIN: INE089A01023 Sector: Pharma. Summary. Charts. F&O. News. Research. Financials. …
Webthe US SEC for the fiscal year ended March 31, 2024 and quarterly financial statements filed in Form 6-K with the US SEC for the quarters ended Jun 30, 2024, Sep 30, 2024, ... This presentation is property of Dr. Reddy's Laboratories Limited. Do not alter in any way or reproduce without permission. inciweb.com flagstaffWebFY'22 was a year of good financial performance with growth in sales and EBITDA, and strong cash flow generation from operations. Revenue stood at ` 21,439 cr or $2.83 … inbox dollars daily activityWebDr. Reddy's Laboratories Ltd. ADR annual income statement. View RDY financial statements in full, including balance sheets and ratios. Dow Jones, a News Corp … inbox dollars no phoneWebApr 12, 2024 · Erez Israeli. Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company’s Global Generics segment manufactures and markets ... inbox dollars earn per surveyWebDr. Reddy's Laboratories Ltd. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View DRREDDY.IN financial statements in full. inbox dollars offers not creditingWeb7 Dr. Reddy’s Laboratories Louisi Subsidiary 100 8 Reddy Pharma Italia S.R.L. Subsidiary 100 9 Dr. Reddy’s S.R.L. Subsidiary 100 10 Reddy Pharma Iberia S.A.U. Subsidiary 100 11 Dr. Reddy’s Farmaceutica Do B Subsidiary 100 12 Dr. Reddy’s Laboratories (UK) L Subsidiary 100 13 Dr. Reddy’s Laboratories (EU) L Subsidiary 100 inciweb yosemiteWeb1 Dr. Reddy's New Zealand Limit Subsidiary 100 2 Dr. Reddy’s Laboratories (Austr Subsidiary 100 3 Dr. Reddy’s Laboratories (Prop Subsidiary 100 4 Dr. Reddy's Venezuela, C.A. Subsidiary 100 5 Dr. Reddy’s Laboratories, Inc. Subsidiary 100 6 Promius Pharma, LLC Subsidiary 100 7 Dr. Reddy’s Laboratories Louisi Subsidiary 100 incizo threshold